Heres what to know: Hunger may return : GLP-1s work in part by reducing appetite
When you remove that dual stimulation during a switch, the transition period requires careful dose management to prevent rebound effects
Multisite research, including research at UAB, shows that oral semaglutide is nearly as effective as the widely used injectable version for treating obesity, delivering about 13.7 percent average weight loss over 64 weeks
Fortin SM, Lipsky RK, Lhamo R, Chen J, Kim E, Borner T, et al
[6,7] GLP-1 receptor agonist medications may cause some side effects, which vary depending on the individual